Cormorant Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-88,700	Closed	-$12.4M	–	77
2019 Q3	$12.4M	Sell	88,700 -11,300	-11%	-$1.89M	0.76%	39
2019 Q2	$18.3M	Sell	100,000 -30,000	-23%	-$5.12M	1.05%	32
2019 Q1	$20.7M	Sell	130,000 -53,732	-29%	-$7.78M	1.4%	27
2018 Q4	$17.6M	Sell	183,732 -6,268	-3%	-$717K	1.43%	27
2018 Q3	$26.8M	Sell	190,000 -49,619	-21%	-$7.66M	1.74%	22
2018 Q2	$37.5M	Hold	239,619	–	–	2.78%	11
2018 Q1	$38.6M	Buy	+239,619	New	+$40.7M	2.88%	8
2016 Q3	–	Sell	-730,000	Closed	-$22M	–	90
2016 Q2	$22M	Sell	730,000 -215,000	-23%	-$7.17M	3.12%	8
2016 Q1	$30.3M	Buy	945,000 +630,000	+200%	+$22.2M	4.56%	3
2015 Q4	$18.4M	Buy	315,000 +75,000	+31%	+$3.72M	2.2%	12
2015 Q3	$10.2M	Buy	+240,000	New	+$14.8M	1.62%	21
2015 Q2	–	Sell	-850	Closed	-$43K	–	84
2015 Q1	$43K	Sell	850 -150	-15%	-$6.45K	0.01%	71
2014 Q4	$37K	Sell	1,000 -9,000	-90%	-$335K	0.01%	70
2014 Q3	$315K	Buy	+10,000	New	+$290K	0.06%	65